2007-March Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Thu Mar 1 05:09:23 2007
Ending: Sat Mar 31 19:44:29 2007
Messages: 198

• [Ip-health] Combivir patent rejected in China   James ARKINSTALL
• [Ip-health] SciDev.Net editorial: time for action on patents   James ARKINSTALL
• [Ip-health] KEI Brownbag this Thursday: Sakiko Fukuda-Parr on The Gene Revolution   Malini Aisola
• [Ip-health] REMINDER: KEI Brownbag TODAY on The Gene Revolution   Malini Aisola
• [Ip-health] Re: [aidsdrugs] Abbott Abusive Registration Practices   B.Baker@neu.edu
• [Ip-health] Abbott - A New Low in the Pharma Drug Wars   B.Baker@neu.edu
• [Ip-health] Bridges Weekly: BREAKTHROUGH ON WIPO DEVELOPMENT AGENDA   Thiru Balasubramaniam
• [Ip-health] Dates for June WIPO PCDA and SCCR meetings   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Global Health, China's Pride On Line in Malaria Clash   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Novartis Angers Critics in India   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: BANGLADESH AND BOLIVIA CALL FOR EXTENSION OF WHO WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY   Thiru Balasubramaniam
• [Ip-health] IP-Watch (Monthly Edition): WIPO Development Agenda Negotiation Surges Ahead   Thiru Balasubramaniam
• [Ip-health] Letter from 12 U.S. Congress members to USTR Representative Susan Schwab: US Trade Policies Restrict Access to Life Saving Medicines   Thiru Balasubramaniam
• [Ip-health] Ronald A. Cass in the Wall Street Journal: Thai Patent Turmoil   Thiru Balasubramaniam
• [Ip-health] Letters to Wall Street Journal from KEI, IFPMA and Oxfam on "Bangkok's Drug War Goes Global" editorial   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal editorial: The Thai Flu   Thiru Balasubramaniam
• [Ip-health] Le Temps (Swiss newspaper): Abbott ne laisse pas intimider en Thailande   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: AGREEMENT ELUDES US AND KOREA IN FTA TALKS, DESPITE PROGRESS   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: THAI GOVERNMENT EXPLAINS COMPULSORY LICENCE POLICY ON PATENTED DRUGS   Thiru Balasubramaniam
• [Ip-health] AP: Thai Health Groups Urge Abbott Boycott   Thiru Balasubramaniam
• [Ip-health] Reuters: Thailand Talking with Drug Firms - U.S. Chamber   Thiru Balasubramaniam
• [Ip-health] IPS: US Pharma Giant Faces Public Boycott   Thiru Balasubramaniam
• [Ip-health] Wall Street journal: Poor Countries Seek Pact On Avian-Flu Vaccines   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Democrats' New Trade Agenda May Stall Broader Bush Goals   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: Indonesia to Resume Sharing Bird-Flu Virus Samples   Thiru Balasubramaniam
• [Ip-health] Financial Times: Corners are cut in order to bring drugs to Africa   Thiru Balasubramaniam
• [Ip-health] Washington Post Editorial: A Dose of Innovation   Thiru Balasubramaniam
• [Ip-health] Dean Baker: Thailand takes the lead in promoting free trade   Dan Beeton
• [Ip-health] Tuberculosis. Forgotten, but not gone: from the economist   Rosa Castro
• [Ip-health] Kenya: Pfizer launches first-ever challenge at the IP Tribunal   Christa Cepuch
• [Ip-health] Empirical Paper on ARVs in Sub-Saharan Africa   Colleen Chien
• [Ip-health] Concern about benefits of RED aids campaign   Michelle Childs
• [Ip-health] Pre G8 UK Parliament Event with Hilary Benn and Day of Action 20th March   Michelle Childs
• [Ip-health] Fwd: [A2k] massive attack on Brazil's IPR policies   Michelle Childs
• [Ip-health] Thailand's government use licences   Peter Drahos
• [Ip-health] Mashelkar committee report   Graham Dutfield
• [Ip-health] Mike's notes on Korea meeting   Sean Flynn
• [Ip-health] State impacts of Korea FTA   Sean Flynn
• [Ip-health] Abbott's anticompetitive practices in Thailand   Sean Flynn
• [Ip-health] Shamnad Basheer on India's New Patent Regime   Sean Flynn
• [Ip-health] PUBPAT News: PUBPAT Takes On Key HIV/AIDS Drug Patents   Public Patent Foundation
• [Ip-health] INTELLECTUAL PROPERTY AND ACCESS TO TREATMENT: HOW CAN PATENT LAW WORK FOR PUBLIC HEALTH?   Caroline Gallant
• [Ip-health] Novartis letter to the MEPs requesting them to not sign the Written Declaration. In the Declaration MEPs call Novartis to withdraw the case and call the EU Commission and EU Council to take a similar position   Alexandra HEUMBER
• [Ip-health] Vasella questioned at the General Meeting in Basel about Novartislegal action against India   Alexandra HEUMBER
• [Ip-health] Richard Rockefeller, Times of India Editorial published today   Alexandra HEUMBER
• [Ip-health] "Mandelson keeps mum on Indian drugs case"   Alexandra HEUMBER
• [Ip-health] Who will be sued next? - Scrip editorial   Ellen T HOEN
• [Ip-health] The economist on Prizes for Innovation   Ellen 't Hoen
• [Ip-health] Activists push for global boycott   Kannikar KIJTIWATCHAKUL
• [Ip-health] Lancet: WHO and Abbott in Thailand   Kannikar KIJTIWATCHAKUL
• [Ip-health] Compulsory licensing of patents under ebay decision   Amy Kapczynski
• [Ip-health] Amazon promotes essential facilities, reasonable royalty rules   Amy Kapczynski
• [Ip-health] possible legislation to raise standards for US patents   Benjamin Krohmal
• [Ip-health] KEI Brown Bag: Hanson on Grants vs. Prizes for Innovation   Benjamin Krohmal
• [Ip-health] Stiglitz on medical innovation prizes   Benjamin Krohmal
• [Ip-health] REMINDER: KEI Brown Bag this Friday   Benjamin Krohmal
• [Ip-health] Abbott won't launch new drugs in Thailand   Benjamin Krohmal
• [Ip-health] WSJ: "Why Generic Doesn't Always Mean Cheap"   Benjamin Krohmal
• [Ip-health] Friday Capitol Hill Briefing on Thailand Situation   Benjamin Krohmal
• [Ip-health] Thailand briefing details   Benjamin Krohmal
• [Ip-health] comments from Abbott, Thailand   Benjamin Krohmal
• [Ip-health] MSF Denounces Abbott's Move to Withhold Medicines From People in Thailand   Benjamin Krohmal
• [Ip-health] Bayer supports Abbott's move in Thailand   Benjamin Krohmal
• [Ip-health] US law on govt. use of patents   Benjamin Krohmal
• [Ip-health] US Supreme Court may hear pharma antitrust case   Benjamin Krohmal
• [Ip-health] Petition: support public access to medical research   Benjamin Krohmal
• [Ip-health] Investors criticize Abbott   Benjamin Krohmal
• [Ip-health] U.S. Pres. candidate on Thailand & global framework   Benjamin Krohmal
• [Ip-health] A US court judgment that is relevant to Novartis case   Benjamin Krohmal
• [Ip-health] compulsory license boosts Abbott profits   Benjamin Krohmal
• [Ip-health] Philippines: U.S. Norvasc ruling supports IP reform   Benjamin Krohmal
• [Ip-health] Mashelkar Plagiarism Controversy-2   Lawrence Liang
• [Ip-health] MSF study on second-line AIDS treatment in resource poor settings: But Access to newer medicines remains an alarming proglem   Buddhima Lokuge
• [Ip-health] Launch of new non-patented Low-Cost Antimalaria medicine   Buddhima Lokuge
• [Ip-health] MSF's response to WSJ Editorial on March 7, 2007   Buddhima Lokuge
• [Ip-health] Abbott excessive pricing of AIDS drug investigation likely in US   Buddhima Lokuge
• [Ip-health] MSF. Abbott should reconsider its unacceptable decision   Buddhima Lokuge
• [Ip-health] patent save lifes - Brazilian Directof of corporate Affairs of Novartis in the Gazeta Mercatil - Brazil   MSF Michel Lotrowska
• [Ip-health] $250,000 Open Architecture Prize prize for developing world.   James Love
• [Ip-health] France - GSK found guilty of predatory pricing to hinder generic entry   James Love
• [Ip-health] Setting a price for putting off death: A few more months of life may not be worth the costs of new cancer therapies, some argue.   James Love
• [Ip-health] Bangladesh submission to WHO IGWG on Public Health, Innovation and Intellectual Property Rights   James Packard Love
• [Ip-health] Submission to WHO/IGWG by Bolivia, in Spanish   James Packard Love
• [Ip-health] English translation: Submission to WHO/IGWG by Bolivia   James Packard Love
• [Ip-health] Brazil submission to WHO/IGWG   James Packard Love
• [Ip-health] Compulsory licensing of patents: Communique issued by the French Minister for Research, Paris 07.09.2001   James Packard Love
• [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   James Packard Love
• [Ip-health] George Washington University's CIEC's "Partners"   James Packard Love
• [Ip-health] Manufacturing costs for second line AIDS drugs   James Packard Love
• [Ip-health] PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS   James Packard Love
• [Ip-health] Recent examples of the use of compulsory licenses on patents   James Packard Love
• [Ip-health] About Mr Myc Riggulsford   James Packard Love
• [Ip-health] Statement in the British Parliament on Thailand CL   James Packard Love
• [Ip-health] Highlights from the European Union's 17 May 2007 regulation on compulsory licensing   James Packard Love
• [Ip-health] Highlights from the European Union's 17 May 2007 regulation on compulsory licensing   James Packard Love
• [Ip-health] Re: [aidsdrugs] Abbott Abusive Registration Practices   James Packard Love
• [Ip-health] March 8, 2007 Geneva Q&A Session on Thai White Paper   James Packard Love
• [Ip-health] Doctors' Ties to Drug Makers Are Put on Close View   James Packard Love
• [Ip-health] Compulsory licensing of patents under ebay decision   James Packard Love
• [Ip-health] University of Arkansas immunity from patent infringment   James Packard Love
• [Ip-health] Compulsory licensing of patents under ebay decision   James Packard Love
• [Ip-health] The Big Idea: Prizes to Stimulate R&D for New Medicines   James Packard Love
• [Ip-health] Italy issues compulsory license on Merck drug   James Packard Love
• [Ip-health] More on the Italian compulsory license for finasteride   James Packard Love
• [Ip-health] VBB on Merck Italian CL   James Packard Love
• [Ip-health] Georges and Bay on "the Italian Case"   James Packard Love
• [Ip-health] Two other Italian CLs, GSK's migraine drug, and Merck's broad spectrum antibiotic   James Packard Love
• [Ip-health] It: official press release on finasteride CL, (also mentions the two previous CL cases)   James Packard Love
• [Ip-health] Changes in US patent review process   Rohit Malpani
• [Ip-health] New Oxfam briefing paper on the costs and benefits of the US - Jordan free trade agreement   Rohit Malpani
• [Ip-health] Compulsory licensing of patents under ebay decision   Anne St. Martin
• [Ip-health] Legal Analysis of Patent Breaking/Compulsory Licensing in the Face of Public Health Crisis   Chris Nidel
• [Ip-health] Lisa Conte in Huffington Post on Novartis Case   Mike Palmedo
• [Ip-health] IP-Watch: Thailand Presents Report On Compulsory Licensing Experience   Mike Palmedo
• [Ip-health] Colombian study on impact of FTA on medicines   Mike Palmedo
• [Ip-health] PIJIP Analysis of Thai Law on Government Use Licenses   Mike Palmedo
• [Ip-health] LA Times: Setting a Price for Putting Off Death   Mike Palmedo
• [Ip-health] The Hill: House Democrats scrutinize price tag of AIDS drug   Mike Palmedo
• [Ip-health] PhRMA testimony at House Ways and Means Subcommittee on Trade   Mike Palmedo
• [Ip-health] US Chamber of Commerce on Thailand's IP   Mike Palmedo
• [Ip-health] A Drug Deal Gone Bad - by Sean Flynn and Sharon Treat in Tompaine.com   Mike Palmedo
• [Ip-health] Reuters: Korea FTA Talks Stumble at Last Minute   Mike Palmedo
• [Ip-health] =?Windows-1252?Q?Mint_India:_There=92s_a_lesson_to_be_learnt_here=2C_says?= =?Windows-1252?Q?_Mashelkar?=   Achal Prabhala
• [Ip-health] Frontline: Cleaning up after Mashelkar - Praful Bidwai   Achal Prabhala
• [Ip-health] Frontline: Batting for MNCs - Dinesh Abrol   Achal Prabhala
• [Ip-health] Frontline: Against Monopoly - Yusuf Hamied   Achal Prabhala
• [Ip-health] ZeeNews: Mashelkar can resubmit report - Govt   Achal Prabhala
• [Ip-health] Business Standard: Mashelkar gets time to purge `follies`   Achal Prabhala
• [Ip-health] The Hindu: Expert group to review Mashelkar report   Achal Prabhala
• [Ip-health] Times of India: Interest Group Capture - Sudhir Krishnaswamy   Achal Prabhala
• [Ip-health] The Hindu: Time for international action on patents   Achal Prabhala
• [Ip-health] Times of India: Mashelkar panel member in favour of fresh 'conclusions'   Achal Prabhala
• [Ip-health] EPW: Is Plagiarism the only problem with the Mashelkar report?   Achal Prabhala
• [Ip-health] Indian Express: Terra pharma   Achal Prabhala
• [Ip-health] Nature: Plagiarised report on patent laws shames Indian scientists   Achal Prabhala
• [Ip-health] Hindu interviews on Novartis Case   Ragavan, Srividhya
• [Ip-health] Caution over Swiss Firm Patenting Cancer-fighting Drug   Joana Ramos
• [Ip-health] FDA warns drugmakers over unapproved headache drugs   Joana Ramos
• [Ip-health] Glivec raises concerns on post-marketing study (factiva)]   Joana Ramos
• [Ip-health] Celgene, Novartis File Suit to Block Generic Ritalin   Joana Ramos
• [Ip-health] Novartis Image Shaken with GIPAP Scandal   Joana Ramos
• [Ip-health] [Fwd: [NHeLP] Job Opening: Staff Attorney at PAL   Joana Ramos
• [Ip-health] Glivec Controversy : Spanner In The Works   Joana Ramos
• [Ip-health] Novartis's Rebuttal: Glivec Controversy: Spanner In The Works   Joana Ramos
• [Ip-health] Who is SIGWatch and where does it get its info on patents cases?   Joana Ramos
• [Ip-health] For Alexion, Third Time's The Charm...new drug, Soliris, to treat a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH).   Joana Ramos
• [Ip-health] [Fwd: Litigation & Enforement in the Biotech and Pharmaceutical Industry Conference - One Month Left to Register]   Joana Ramos
• [Ip-health] 2007 Accelerating Anticancer Agent Development and Validation Workshop   Joana Ramos
• [Ip-health] Drug firms' funding of advocates often escapes government scrutiny   Joana Ramos
• [Ip-health] A US court judgment that is relevant to Novartis case   Joana Ramos
• [Ip-health] Fwd:: 60 Minutes Takes on the Drug Industry: Sunday, April 1st (No Joke)]   Joana Ramos
• [Ip-health] Compulsory Licences could save 1Bln baht   Sarah Rimmington
• [Ip-health] Washington Times Op-ed: The Innovation Agenda   Sarah Rimmington
• [Ip-health] Editorial: Putting meaning back into TRIPS   Sarah Rimmington
• [Ip-health] Thailand/New business model for innovation and Thai Govt/Pharma talks   Sarah Rimmington
• [Ip-health] SUNS: Drug-resistant TB treatment barely succeeds   Sangeeta
• [Ip-health] Sanofi trying a deal in Thailand   Judit Rius Sanjuan
• [Ip-health] Korea hearing and health: Rep. Blumenauer's tobacco questions, pharma   Ellen Shaffer
• [Ip-health] Congress Leaders to USTR: Drop TRIPS-Plus in FTAs   Ellen Shaffer
• [Ip-health] Ways & Means statement   Ellen Shaffer
• [Ip-health] now online - Ways & Means statement   Ellen Shaffer
• [Ip-health] Fwd: [G & H] CPATH: Korea, meds, tobacco   Ellen Shaffer
• [Ip-health] Thailand, Wall Street Journal and Media Prostitution   Daya Shanker
• [Ip-health] TRIPS, Mashelkar and Administrative Perversion   Daya Shanker
• [Ip-health] Re: [e-drug] Abbott Withdraws Seven Medicines in Thailand   Mira Shiva
• [Ip-health] [UAEM] Universities Release Best Practices for Licensing "In the Public Interest"   Robynn Sturm
• [Ip-health] Merck's Murky Dealings: HPV Vaccine Lobby Backfires   Riaz K Tayob
• [Ip-health] TNA: EC "concerned" over Thai CLs   Khalil Elouardighi - Act Up-Paris
• [Ip-health] France gives public support to Thai CLs   Khalil Elouardighi - Act Up-Paris
• [Ip-health] LeMonde on Thai CL, France, Abbott   Khalil Elouardighi - Act Up-Paris
• [Ip-health] Compulsory licensing of patents under ebay decision   Luis Villarroel Villalon
• [Ip-health] 'All costs, no benefits: How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines'.   Elizabeth Wabuge
• [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global   Jeff Williams
• [Ip-health] A US court judgment that is relevant to Novartis case   Jeff Williams
• [Ip-health] Notes from D.C. Thailand Breifing   ben.krohmal@keionline.org
• [Ip-health] Abbott criticized; silent on Thailand   ben.krohmal@keionline.org
• [Ip-health] Newsweek: Thailand's New Drug War   ben.krohmal@keionline.org
• [Ip-health] Email alert: March issue of the WHO Bulletin   bulletin
• [Ip-health] Compulsory licensing of patents under ebay decision   michael.davis@law.csuohio.edu
• [Ip-health] Times of India Editorial, Generic drugs only hope for many AIDS, Cancer Patients   msfh-india-medco-assist
• [Ip-health] Democratic Urged USTR to Change Course in US-Korea FTA Negotiations   heeseob nam
• [Ip-health] (no subject)   chan park
• [Ip-health] Novartis Hearing Update, 6.3.07   chan park
• [Ip-health] The Hindu: Dilip Shah of IPA on Mashelkar Report   chan park
• [Ip-health] The Hindu: Mashelkar quits patents expert panel   chan park
• [Ip-health] Economic Times: DIPP Opposes Mashelkar Suggestions   chan park
• [Ip-health] Novartis Update, 26.3.07   chan park
• [Ip-health] A US court judgment that is relevant to Novartis case   chan park
• [Ip-health] Novartis Update, 27.3.07   chan park
• [Ip-health] Novartis Update, 28.3.07   chan park
• [Ip-health] Novartis Update, 29.03.07   chan park
• [Ip-health] Novartis Update, 30.03.07   chan park
• [Ip-health] Mashelkar resigns   kannamma raman
• [Ip-health] IPN et. al.: UN, =?windows-1252?Q?governments=92_policies_ca?= =?windows-1252?Q?use_avoidable_disease_and_suffering?=   robert weissman
• [Ip-health] Pepfar, Generics, Price   robert weissman
• [Ip-health] US Commerce Secty Gutierrez Criticizes Thai CL   robert weissman
• [Ip-health] Amazon promotes essential facilities, reasonable royalty rules   robert weissman

Last message date: Sat Mar 31 19:44:29 2007
Archived on: Sat Mar 31 19:44:30 2007

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...